Neurologic Infections in Travelers

Abstract

This review will provide an outline of the neurological complications of specific parasitic, bacterial, and viral infectious diseases that can affect the international traveler. We will discuss the epidemiology, life cycle, ecology, clinical manifestation, diagnosis, treatment, and prevention.

Keywords

neurological disease - infectious diseases - travel

• References

• 1 Leder K, Torresi J, Libman MD. , et al; GeoSentinel Surveillance Network. GeoSentinel surveillance of illness in returned travelers, 2007-2011. Ann Intern Med 2013; 158 (06) 456-468
• 2 Han MH, Zunt JR. Neurologic aspects of infections in international travelers. Neurologist 2005; 11 (01) 30-44
• 3 World Health Organization Fact Sheets. Schistosomiasis. 2018 . Available at: http://www.who.int/news-room/fact-sheets/detail/schistosomiasis . Accessed September 9, 2018
• 4 Carod-Artal FJ. Neurological complications of Schistosoma infection. Trans R Soc Trop Med Hyg 2008; 102 (02) 107-116
• 5 Walker MD, Zunt JR. Neuroparasitic infections: cestodes, trematodes, and protozoans. Semin Neurol 2005; 25 (03) 262-277
• 6 Ferrari TC, Moreira PR. Neuroschistosomiasis: clinical symptoms and pathogenesis. Lancet Neurol 2011; 10 (09) 853-864
• 7 Thakur K, Zunt J. Tropical neuroinfectious diseases. Continuum (Minneap Minn) 2015; 21 (6 Neuroinfectious Disease): 1639-1661
• 8 World Health Organization Fact Sheets. Trypanosomiasis, human African (sleeping sickness). 2018 . Available at: http://www.who.int/news-room/fact-sheets/detail/trypanosomiasis-human-african-(sleeping-sickness) . Accessed September 13, 2018
• 9 Kennedy PG. Clinical features, diagnosis, and treatment of human African trypanosomiasis (sleeping sickness). Lancet Neurol 2013; 12 (02) 186-194
• 10 World Health Organization Fact Sheets. Chagas disease (American trypanosomiasis). 2018 . Available at: https://www.who.int/news-room/fact-sheets/detail/chagas-disease-(american-trypanosomiasis) . Accessed September 13, 2018
• 11 Centers for Disease Control and Prevention Resources for Health Professionals. Parasites – American trypanosomiasis (also known as Chagas disease). 2018. Available at: https://www.cdc.gov/parasites/chagas/health_professionals/index.html . Accessed September 15, 2018
• 12 Córdova E, Maiolo E, Corti M, Orduña T. Neurological manifestations of Chagas' disease. Neurol Res 2010; 32 (03) 238-244
• 13 Berkowitz AL, Raibagkar P, Pritt BS, Mateen FJ. Neurologic manifestations of the neglected tropical diseases. J Neurol Sci 2015; 349 (1–2): 20-32
• 14 Cougo-Pinto PT, Dos Santos BL, Dias FA. , et al. Safety of IV thrombolysis in acute ischemic stroke related to Chagas disease. Neurology 2013; 81 (20) 1773-1775
• 15 Newton CR, Hien TT, White N. Cerebral malaria. J Neurol Neurosurg Psychiatry 2000; 69 (04) 433-441
• 16 Shikani HJ, Freeman BD, Lisanti MP, Weiss LM, Tanowitz HB, Desruisseaux MS. Cerebral malaria: we have come a long way. Am J Pathol 2012; 181 (05) 1484-1492
• 17 Mishra SK, Newton CR. Diagnosis and management of the neurological complications of falciparum malaria. Nat Rev Neurol 2009; 5 (04) 189-198
• 18 Bill and Melinda Gates Foundation. What we do—malaria: strategy overview. Available at: https://www.gatesfoundation.org/What-We-Do/Global-Health/Malaria . Accessed September 18, 2018
• 19 World Health Organization Fact Sheets. Meningococcal meningitis. 2018. Available at: http://www.who.int/news-room/fact-sheets/detail/meningococcal-meningitis . Accessed September 20, 2018
• 20 Serra LC, York LJ, Gamil A, Balmer P, Webber C. A review of meningococcal disease and vaccination recommendations for travelers. Infect Dis Ther 2018; 7 (02) 219-234
• 21 Pelton SI. The global evolution of meningococcal epidemiology following the introduction of meningococcal vaccine. J Adolesc Health 2016; 59 (2, Suppl): S3-S11
• 22 Stein-Zamir C, Shoob H, Sokolov I, Kunbar A, Abramson N, Zimmerman D. The clinical features and long-term sequelae of invasive meningococcal disease in children. Pediatr Infect Dis J 2014; 33 (07) 777-779
• 23 Kotilainen P, Jalava J, Meurman O. , et al. Diagnosis of meningococcal meningitis by broad-range bacterial PCR with cerebrospinal fluid. J Clin Microbiol 1998; 36 (08) 2205-2209
• 24 Nadel S. Treatment of meningococcal disease. J Adolesc Health 2016; 59 (2, Suppl): S21-S28
• 25 Xu G, Walker DH, Jupiter D, Melby PC, Arcari CM. A review of the global epidemiology of scrub typhus. PLoS Negl Trop Dis 2017; 11 (11) e0006062
• 26 Weitzel T, Dittrich S, López J. , et al. Endemic scrub typhus in South America. N Engl J Med 2016; 375 (10) 954-961
• 27 Rapsang AG, Bhattacharyya P. Scrub typhus. Indian J Anaesth 2013; 57 (02) 127-134
• 28 Mahajan SK, Mahajan SK. Neuropsychiatric manifestations of scrub typhus. J Neurosci Rural Pract 2017; 8 (03) 421-426
• 29 Pai H, Sohn S, Seong Y, Kee S, Chang WH, Choe KW. Central nervous system involvement in patients with scrub typhus. Clin Infect Dis 1997; 24 (03) 436-440
• 30 El Sayed I, Liu Q, Wee I, Hine P. Antibiotics for treating scrub typhus. Cochrane Database Syst Rev 2018; 9: CD002150
• 31 World Health Organization. Zoonoses. 2018 . Available at: http://www.who.int/zoonoses/diseases/lerg/en/index2.html . Accessed September 23, 2018
• 32 Levett PN. Leptospirosis. Clin Microbiol Rev 2001; 14 (02) 296-326
• 33 Gancheva GI, Kostadinova MA, Kostadinova PI. Involvement of central nervous system in leptospirosis. J Biomed Clin Res. 2009; 2 (02) 109-114
• 34 Panicker JN, Mammachan R, Jayakumar RV. Primary neuroleptospirosis. Postgrad Med J 2001; 77 (911) 589-590
• 35 Chiappe-Gonzalez A, Ticona-Huaroto C, Hoerster V. , et al. Primary neuroleptospirosis: a case report and literature review. Infect Dis Clin Pract 2017; 25: 329-331
• 36 Wilson MR, Naccache SN, Samayoa E. , et al. Actionable diagnosis of neuroleptospirosis by next-generation sequencing. N Engl J Med 2014; 370 (25) 2408-2417
• 37 de Vries SG, Visser BJ, Stoney RJ. , et al; For The GeoSentinel Surveillance Network. Leptospirosis among returned travelers: a GeoSentinel survey and multicenter analysis 1997–2016. Am J Trop Med Hyg 2018; 99 (01) 127-135
• 38 Smythe LD, Wuthiekanun V, Chierakul W. , et al. The microscopic agglutination test (MAT) is an unreliable predictor of infecting Leptospira serovar in Thailand. Am J Trop Med Hyg 2009; 81 (04) 695-697
• 39 Brett-Major DM, Coldren R. Antibiotics for leptospirosis. Cochrane Database Syst Rev 2012; 2 (02) CD008264
• 40 Takafuji ET, Kirkpatrick JW, Miller RN. , et al. An efficacy trial of doxycycline chemoprophylaxis against leptospirosis. N Engl J Med 1984; 310 (08) 497-500
• 41 Zhao S, Cheng Y, Liao Y, Zhang Z, Yin X, Shi S. Treatment efficacy and risk factors or neurobrucellosis. Med Sci Monit 2016; 22: 1005-1012
• 42 Guven T, Ugurlu K, Ergonul O. , et al. Neurobrucellosis: clinical and diagnostic features. Clin Infect Dis 2013; 56 (10) 1407-1412
• 43 Centers for Disease Control and Prevention. Brucellosis Reference Guide: exposures, testing, and prevention. 2017. Available at: https://www.cdc.gov/brucellosis/pdf/brucellosi-reference-guide.pdf . Accessed September 26, 2018
• 44 Corbel MJ. Brucellosis in humans and animals. 2006 . Available at: https://www.who.int/csr/resources/publications/Brucellosis.pdf . Accessed April 4, 2019
• 45 Gul HC, Erdem H, Bek S. Overview of neurobrucellosis: a pooled analysis of 187 cases. Int J Infect Dis 2009; 13 (06) e339-e343
• 46 Al Dahouk S, Tomaso H, Nöckler K, Neubauer H, Frangoulidis D. Laboratory-based diagnosis of brucellosis--a review of the literature. Part II: serological tests for brucellosis. Clin Lab 2003; 49 (11–12): 577-589
• 47 Erdem H, Ulu-Kilic A, Kilic S. , et al. Efficacy and tolerability of antibiotic combinations in neurobrucellosis: results of the Istanbul study. Antimicrob Agents Chemother 2012; 56 (03) 1523-1528
• 48 Pappas G, Akritidis N, Christou L. Treatment of neurobrucellosis: what is known and what remains to be answered. Expert Rev Anti Infect Ther 2007; 5 (06) 983-990
• 49 Mehta R, Soares CN, Medialdea-Carrera R. , et al. The spectrum of neurological disease associated with Zika and chikungunya viruses in adults in Rio de Janeiro, Brazil: A case series. PLoS Negl Trop Dis 2018; 12 (02) e0006212
• 50 Calvet GA, Santos FB, Sequeira PC. Zika virus infection: epidemiology, clinical manifestations and diagnosis. Curr Opin Infect Dis 2016; 29 (05) 459-466
• 51 Chen TH, Staples E, Fisher M. CDC Yellow Book 2018: Health Information for International Travel. Chapter 3: Zika. February 2018. Available at: https://wwwnc.cdc.gov/travel/yellowbook/2018/infectious-diseases-related-to-travel/zika . Accessed October 26, 2018
• 52 Parra B, Lizarazo J, Jiménez-Arango JA. , et al. Guillain-Barré syndrome associated with zika virus infection in Colombia. N Engl J Med 2016; 375 (16) 1513-1523
• 53 Rabe IB, Staples JE, Villanueva J. , et al; MTS. Interim guidance for interpretation of Zika virus antibody test results. MMWR Morb Mortal Wkly Rep 2016; 65 (21) 543-546
• 54 do Rosário MS, de Jesus PA, Vasilakis N. , et al. Guillain-Barré syndrome after zika virus infection in Brazil. Am J Trop Med Hyg 2016; 95 (05) 1157-1160
• 55 Chancey C, Grinev A, Volkova E, Rios M. The global ecology and epidemiology of West Nile virus. BioMed Res Int 2015; 2015: 376230
• 56 Hart Jr J, Tillman G, Kraut MA. , et al; NIAID Collaborative Antiviral Study Group West Nile Virus 210 Protocol Team. West Nile virus neuroinvasive disease: neurological manifestations and prospective longitudinal outcomes. BMC Infect Dis 2014; 14: 248
• 57 World Health Organization Fact Sheets. West Nile virus. 2018 . Available at: http://www.who.int/news-room/fact-sheets/detail/west-nile-virus . Accessed October 1, 2018
• 58 Centers for Disease Control and Prevention. West Nile virus: information for healthcare providers. 2018. Available at: https://www.cdc.gov/westnile/healthcareproviders/index.html . Accessed October 1, 2018
• 59 Sejvar JJ. The long-term outcomes of human West Nile virus infection. Clin Infect Dis 2007; 44 (12) 1617-1624
• 60 World Health Organization Fact Sheets. Japanese encephalitis. 2015 . Available at: http://www.who.int/news-room/fact-sheets/detail/japanese-encephalitis . Accessed October 1, 2018
• 61 Hills SL, Rabe IB, Fischer M. CDC Yellow Book 2018: Health Information for International Travel. Chapter 3: Japanese encephalitis. February 2018. Available at: https://wwwnc.cdc.gov/travel/yellowbook/2018/infectious-diseases-related-to-travel/japanese-encephalitis . Accessed October 6, 2018
• 62 Knust B, Choi M. CDC Yellow Book 2018: Health Information for International Travel. Chapter 3: Viral hemorrhagic fevers. February 2018. Available at: https://wwwnc.cdc.gov/travel/yellowbook/2018/infectious-diseases-related-to-travel/viral-hemorrhagic-fevers . Accessed October 25, 2018
• 63 Boushab BM, Fall-Malick FZ, Ould Baba SE. , et al. Severe human illness caused by rift valley fever virus in Mauritania 2015. Open Forum Infect Dis 2016; 3 (04) ofw200
• 64 Okokhere PO, Rafiu MO, Bankole IA. Central nervous system disease associated with major viral haemorrhagic fever viruses of public health importance: challenges in patient diagnosis, evaluation, and management in resource-limited settings. EMJ Neurol 2017; 5 (01) 73-81
• 65 Abreu-Mota T, Hagen KR, Cooper K. , et al. Non-neutralizing antibodies elicited by recombinant Lassa-Rabies vaccine are critical for protection against Lassa fever. Nat Commun 2018; 9 (01) 4223
• 66 Henao-Restrepo AM, Camacho A, Longini IM. , et al. Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!). Lancet 2017; 389 (10068): 505-518
• 67 Ambrosio A, Saavedra M, Mariani M, Gamboa G, Maiza A. Argentine hemorrhagic fever vaccines. Hum Vaccin 2011; 7 (06) 694-700
• 68 Faburay B, LaBeaud AD, McVey DS, Wilson WC, Richt JA. Current status of rift valley fever vaccine development. Vaccines (Basel) 2017; 5 (03) E29
• 69 Singh R, Singh KP, Cherian S. , et al. Rabies - epidemiology, pathogenesis, public health concerns and advances in diagnosis and control: a comprehensive review. Vet Q 2017; 37 (01) 212-251
• 70 Petersen BW, Wallace RM, Shlim DR. CDC Yellow Book 2018: Health Information for International Travel. Chapter 3: Rabies. February 2018. Available at: https://wwwnc.cdc.gov/travel/yellowbook/2018/infectious-diseases-related-to-travel/rabies . Accessed October 15, 2018
• 71 World Health Organization Fact Sheets. Rift Valley fever. 2018. Available at: http://www.who.int/news-room/fact-sheets/detail/rift-valley-fever . Accessed October 10, 2018
• 72 Alexander JP, Patel M, Wassilak SGF. CDC Yellow Book 2018: Health Information for International Travel. Chapter 3: Poliomyelitis. February 2018. Available at: https://wwwnc.cdc.gov/travel/yellowbook/2018/infectious-diseases-related-to-travel/poliomyelitis . Accessed October 26, 2018
• 73 Gonzalez H, Olsson T, Borg K. Management of postpolio syndrome. Lancet Neurol 2010; 9 (06) 634-642
• 74 GBD 2015 Neurological Disorders Collaborator Group. Global, regional, and national burden of neurological disorders during 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Neurol 2017; 16 (11) 877-897